Concepedia

Nichol Miller

NM

Statistics

Publications

31

Citations

2.1K

H-Index

25

Active since

2004

Affiliations

University of California San Diego(Current)

Pfizer (United States)

Moores Cancer Center

UC San Diego Health System

Reproductive Science Center

Nichol Miller is an author at University of California San Diego specializing in life sciences, oncology, and medicine.

Publications per year

2004–2025

31

Publications

31

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 186 citations

, , +14

Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity

Mansi Arora, Justin Moser, Timothy E. Hoffman et al. · Cell · 2023 · 175 citations

, , +16

Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function

Christine Jean, Xiao Lei Chen, Ju‐Ock Nam et al. · The Journal of Cell Biology · 2014 · 172 citations · Full text

, , +17

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

Stefano Crosignani, Patrick Bingham, Pauline Bottemanne et al. · Journal of Medicinal Chemistry · 2017 · 138 citations · Full text

, , +12

Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer

Kevin D. Freeman‐Cook, Robert L. Hoffman, Douglas C. Behenna et al. · Journal of Medicinal Chemistry · 2021 · 117 citations · Full text

, , +12

1–5 of 31